Digital Diagnostics
SF 8.2Autonomous AI for diabetic retinopathy screening
Autonomous AI for diabetic retinopathy screening
AI retinal screening across multiple eye diseases
Quick decision guide
Not enough differentiated product data yet to make a strong automatic pick.
Overview
Digital Diagnostics develops autonomous AI retinal screening technology for primary care sites, with IDx-DR screening retinal images for diabetic retinopathy.
Its suitability depends on condition-specific authorization, image-capture quality, dependable referral pathways, and operational adoption across participating primary care teams.
Eyenuk is an AI retinal-screening platform for primary care and organized screening programs, detecting diabetic retinopathy, diabetic macular edema, and related retinal conditions.
Eyenuk is best evaluated as a screening layer whose value depends on workflow placement, specialist follow-up, and coordinated deployment across participating sites.
Side-by-side
OVERLAP
Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.
Shared capabilities
Shared workflows
Feature check
The trade-offs
Final verdict
Current catalog data shows meaningful overlap between Digital Diagnostics and Eyenuk. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.
Digital Diagnostics and Eyenuk share 10 catalog signals, so the decision should focus on fit rather than broad capability alone.
Digital Diagnostics has 3 visible decision signals and Eyenuk has 3.
Digital Diagnostics has the higher SoftFinders Score in the current catalog data.